Cite
The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions.
MLA
Galloway-Peña, Jessica R., and Dimitrios P. Kontoyiannis. “The Gut Mycobiome: The Overlooked Constituent of Clinical Outcomes and Treatment Complications in Patients with Cancer and Other Immunosuppressive Conditions.” PLoS Pathogens, vol. 16, no. 4, Apr. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1371/journal.ppat.1008353.
APA
Galloway-Peña, J. R., & Kontoyiannis, D. P. (2020). The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions. PLoS Pathogens, 16(4), 1–9. https://doi.org/10.1371/journal.ppat.1008353
Chicago
Galloway-Peña, Jessica R., and Dimitrios P. Kontoyiannis. 2020. “The Gut Mycobiome: The Overlooked Constituent of Clinical Outcomes and Treatment Complications in Patients with Cancer and Other Immunosuppressive Conditions.” PLoS Pathogens 16 (4): 1–9. doi:10.1371/journal.ppat.1008353.